Clinical experience with a new alkylating agent AB-132, in the treatment of lymphomas and leukemias.
D000477:Alkylating Agents; D000970:Antineoplastic Agents / Q000628:therapy*; D001388:Aziridines; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy*
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001388:Aziridines; C024217:meturedepa
ANTINEOPLASTIC AGENTS/therapy; LEUKEMIA/therapy; LYMPHOMA/therapy